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Abstract
Introduction: The main mission of health insurance is to eliminate the niajor barriers to access [o
health care. especially for vulnerable groups in the community. One of the most vulnerable gloups
in receiving health care services is cancer patients *'ho pa1'a lot of rnedical treatment. T'he cost of
medication and treatment is ver,"- high in this group of patients. Therefore. new policies should be
adopted in health insurance plans in order to provide more support for cancer patients. so that they
u,ould not delay treatment due to Lack of Financial capability or high cost of medications. Variable
fi'aLrchise is one of the solutions thai might resolve financial constraints, help to manage costs of
treatmeltt and provide more support 1br vulnerable groups in the comtnttnit.v. The present study
aimed to find out u,l-iellre r curreut fired fi'anchise (lixed pcrcentage) can be convertecl ittto slcpped
or variable franchise.
Methods: This ri,as a descriptive. applied aird conririi-red (qualitative-quantiiiitire) strid'i'.Statistical
population consisted of Oncologists and insured oi Ilan's Health insurance in Ket'uraii province
rvho Have used Of the drues in the Oncology and OTC drugs chercl<list in year Y' 1i "fhs (313
collcction u,as clone usiitg the Deiphi method (Erpert Panel). checltlists of Oncolog-v and OTC
drugs are collectcd front the Kerman Health lnsurance Organization And Was detertrtined the
Vital. Essential. and Corr.ir.r.ror-r oiOncology checklist drugs through a Expert Panel of Oncologists
ot'Kerrnan province.
Data anall,sis u,as doned perfonled using descriptive statistics and Excel Y ' \ l. The Feasibilitl' of
variable franchises e\ertion u'as investigated rvith using frorn trvo scenarios.
Findings: findings shorred That the Kerman's health Insurance can apply variable liaitchise for
Oncology and OTC drues usins from tno scenario... [n the first case scenario" By retroving OTC
dnrgs fiom Kenran's health insurance commitment. u,hich led to saving of'r\ iAV1.o$. Since total
arnount of Oncologl'fl'anchise fbr vital drugs rvas r\1lAi.$. savings can compensate Oncolo-ey
fianchise withor.rt irlposing anr flnancial burden on Kennan's health insurance.
In rhe second sccnario. r,ariable fi'anchise u,as applied to Oncologl, drtigs. Tirat way" Oncology
rirugs through a Expert r:'rnel rr'iLlr Oncology specialists'...,'.g gl2s3iiied into rank I vital. r:rrrL JI
vital. rank III vital. iitnk I essential. rank II essential anci comtnon dr"ugs. Franchise of lanL i i'ital
Onct-ilrlu'drugs ticcreased by I .Z and l -:i iY-\.1 $ rvas allocated to ranli i r ital Oncology dLugs.
Irrauchise of rank II vital oncologl'drugs decreased by t '\l and I \ "\Y-''Y $ rvas allocated to rank
lI vital Oncolog.v drugs. F-ranchise of rank III vital Oncology drugs de creased by a'/. and \ \ ' 1o. i o
$ u,as allocated to rank III vital Oncology drugs. Franchise of rank I essential Oncology drugs
decreased b1,i,Y'/. and f\\ I t.l o $ r.vas ailocated to rank I essentialOncology drugs. Irranchise of
rank II essential Oncology drugs decreased by \ I and I Y 1 Y . i i $ rvas allocated to rank II essential
Oncology drr.rgs.
Clonclusion: tlte results of this study shorved that the Kerman's health Insurance can allow
vLrlrrerable groups oi societ-v more access to esscnlial and hugell' expensive drugs through
reallrcation of rc:iources and cost sliiliin.: fiont [r-.',r cost and high-denranrl drugs to hiqh-cost and
lorv-cJenrand drulss. It also reduced the poteniial tr-. ,nal<e higher cost for the.lb,)ve !lr:,rrT.
So recommended Health lnsurance Organization and other Insurance Organizations In the field of
health; seriously, put up necessary actions for to execute Variable Franchise on your agenda.
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